These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 25369302)
41. The radiological diagnosis of hepatocellular carcinoma. Sherman M Am J Gastroenterol; 2010 Mar; 105(3):610-2. PubMed ID: 20203642 [TBL] [Abstract][Full Text] [Related]
42. HBV-related HCC, clinical issues and therapy. Iavarone M; Colombo M Dig Liver Dis; 2011 Jan; 43 Suppl 1():S32-9. PubMed ID: 21195370 [TBL] [Abstract][Full Text] [Related]
43. Diagnostic and treatment algorithm of the Japanese society of hepatology: a consensus-based practice guideline. Izumi N Oncology; 2010 Jul; 78 Suppl 1():78-86. PubMed ID: 20616588 [TBL] [Abstract][Full Text] [Related]
44. [Diagnosis of hepatocellular carcinoma]. Allgaier HP; Blum U; Deibert P; Spangenberg HC; Blum HE Schweiz Med Wochenschr; 1996 Nov; 126(46):1975-83. PubMed ID: 8984606 [TBL] [Abstract][Full Text] [Related]
45. Imaging of hepatocellular carcinoma and early diagnosis. Limaye AR; Cabrera R Minerva Med; 2010 Dec; 101(6):395-404. PubMed ID: 21196899 [TBL] [Abstract][Full Text] [Related]
46. Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring. Hennedige T; Venkatesh SK Cancer Imaging; 2013 Feb; 12(3):530-47. PubMed ID: 23400006 [TBL] [Abstract][Full Text] [Related]
47. Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study. Borzio M; Fornari F; De Sio I; Andriulli A; Terracciano F; Parisi G; Francica G; Salvagnini M; Marignani M; Salmi A; Farinati F; Carella A; Pedicino C; Dionigi E; Fanigliulo L; Cazzaniga M; Ginanni B; Sacco R; Future Oncol; 2013 Feb; 9(2):283-94. PubMed ID: 23414477 [TBL] [Abstract][Full Text] [Related]
48. [Evaluation of noninvasive diagnostic criteria for hepatocellular carcinoma on pretransplant MRI (2010): correlation between MR imaging features and histological features on liver specimen]. Ouedraogo W; Tran-Van Nhieu J; Baranes L; Lin SJ; Decaens T; Laurent A; Djabbari M; Pigneur F; Duvoux C; Kobeiter H; Deux JF; Rahmouni A; Luciani A J Radiol; 2011; 92(7-8):688-700. PubMed ID: 21819911 [TBL] [Abstract][Full Text] [Related]
49. Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study. Granito A; Galassi M; Piscaglia F; Romanini L; Lucidi V; Renzulli M; Borghi A; Grazioli L; Golfieri R; Bolondi L Aliment Pharmacol Ther; 2013 Feb; 37(3):355-63. PubMed ID: 23199022 [TBL] [Abstract][Full Text] [Related]
50. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Sapisochin G; Fidelman N; Roberts JP; Yao FY Liver Transpl; 2011 Aug; 17(8):934-42. PubMed ID: 21438129 [TBL] [Abstract][Full Text] [Related]
51. Diagnosis of hepatocellular carcinoma: role of tumor markers and liver biopsy. Gonzalez SA; Keeffe EB Clin Liver Dis; 2011 May; 15(2):297-306, vii-x. PubMed ID: 21689614 [TBL] [Abstract][Full Text] [Related]
52. Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma. Kim TK; Lee KH; Jang HJ; Haider MA; Jacks LM; Menezes RJ; Park SH; Yazdi L; Sherman M; Khalili K Radiology; 2011 Jun; 259(3):730-8. PubMed ID: 21364083 [TBL] [Abstract][Full Text] [Related]
53. Comparison of liver biopsy and noninvasive methods for diagnosis of hepatocellular carcinoma. Bialecki ES; Ezenekwe AM; Brunt EM; Collins BT; Ponder TB; Bieneman BK; Di Bisceglie AM Clin Gastroenterol Hepatol; 2006 Mar; 4(3):361-8. PubMed ID: 16527701 [TBL] [Abstract][Full Text] [Related]
54. LI-RADS: a case-based review of the new categorization of liver findings in patients with end-stage liver disease. Purysko AS; Remer EM; Coppa CP; Leão Filho HM; Thupili CR; Veniero JC Radiographics; 2012; 32(7):1977-95. PubMed ID: 23150853 [TBL] [Abstract][Full Text] [Related]
55. MR imaging in cirrhosis and hepatocellular carcinoma. Barr DC; Hussain HK Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):315-35. PubMed ID: 25086932 [TBL] [Abstract][Full Text] [Related]
56. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging. Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI Radiology; 2014 Jun; 271(3):748-60. PubMed ID: 24588677 [TBL] [Abstract][Full Text] [Related]
57. Clinical utility of des-γ-carboxyprothrombin kinetics as a complement to radiologic response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Park WH; Shim JH; Han SB; Won HJ; Shin YM; Kim KM; Lim YS; Lee HC J Vasc Interv Radiol; 2012 Jul; 23(7):927-36. PubMed ID: 22633621 [TBL] [Abstract][Full Text] [Related]
58. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease. Jang KM; Kim SH; Kim YK; Choi D Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304 [TBL] [Abstract][Full Text] [Related]
59. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation. Lao OB; Weissman J; Perkins JD Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644 [TBL] [Abstract][Full Text] [Related]
60. Treatment options for hepatocellular carcinoma. Sandhu DS; Tharayil VS; Lai JP; Roberts LR Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]